
Number of publications published per year by Braconi, Chiara. (Source : PubMed)

Distribution of publications types for Braconi, Chiara. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Modulation of mismatch repair and genomic stability by miR-155.
Proc. Natl. Acad. Sci. U.S.A.
2010

MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes.
Hepatology
2010;51;3
Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes.
Clin. Cancer Res.
2010;16;3
Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.
Cancer
2009;115;16

Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells.
Liver Int.
2009;29;5

Molecular targets in Gastrointestinal Stromal Tumors (GIST) therapy.
Curr Cancer Drug Targets
2008;8;5
Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients.
Ann. Oncol.
2008;19;7


MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors.
Hepatology
2008;47;6

KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study.
Ann. Oncol.
2008;19;4
[ See timeline ] [ See all publications ]
means that Braconi, Chiara has 4 papers cited a least 4 times - methodology
Centro Regionale di Genetica Oncologica-Oncologia Medica, Università Politecnica delle Marche, Ancona, Italy.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.